Zdrowie i gospodarka · 15/02/2013
FDA Releases Guidance on Clinical Study Designs for Surgical Ablation Devices for Atrial Fibrillation Treatment
The Food and Drug Administration (FDA) has made available a guidance document outlining its recommendations for clinical trial designs for surgical ablation devices aimed at treating atrial fibrillation, a type of irregular heartbeat.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →